An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda

被引:55
作者
Barbaric, Ivana [1 ]
Perry, Mark J. [2 ]
Dear, T. Neil [5 ]
Da Costa, Alexandra Rodrigues [2 ]
Salopek, Daniela [3 ]
Marusic, Ana [3 ]
Hough, Tertius [5 ]
Wells, Sara [5 ]
Hunter, A. Jackie [4 ]
Cheeseman, Michael [1 ,5 ]
Brown, Steve D. M. [1 ]
机构
[1] MRC, Mammalian Genet Unit, Harwell, Berks, England
[2] Univ Bristol, Dept Anat, Bristol, Avon, England
[3] Univ Zagreb, Sch Med, Dept Anat, Zagreb 41001, Croatia
[4] GlaxoSmithKline Inc, New Frontiers Sci Pk, Harlow, Essex, England
[5] MRC, Mary Lyon Ctr, Harwell, Berks, England
基金
英国医学研究理事会;
关键词
N-ethyl-N-nitrosourea; osteopenia; Ankrd11;
D O I
10.1152/physiolgenomics.00116.2007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mechanisms that regulate bone mass are important in a variety of complex diseases such as osteopenia and osteoporosis. Regulation of bone mass is a polygenic trait and is also influenced by various environmental and lifestyle factors, making analysis of the genetic basis difficult. As an effort toward identifying novel genes involved in regulation of bone mass, N-ethyl-N-nitrosourea (ENU) mutagenesis in mice has been utilized. Here we describe a mouse mutant termed Yoda that was identified in an ENU mutagenesis screen for dominantly acting mutations. Mice heterozygous for the Yoda mutation exhibit craniofacial abnormalities: shortened snouts, wider skulls, and deformed nasal bones, underlined by altered morphology of frontonasal sutures and failure of interfrontal suture to close. A major feature of the mutant is reduced bone mineral density. Homozygosity for the mutation results in embryonic lethality. Positional cloning of the locus identified a missense mutation in a highly conserved region of the ankyrin repeat domain 11 gene (Ankrd11). This gene has not been previously associated with bone metabolism and, thus, identifies a novel genetic regulator of bone homeostasis.
引用
收藏
页码:311 / 321
页数:11
相关论文
共 32 条
[1]   CRITICAL YEARS AND STAGES OF PUBERTY FOR SPINAL AND FEMORAL BONE MASS ACCUMULATION DURING ADOLESCENCE [J].
BONJOUR, JP ;
THEINTZ, G ;
BUCHS, B ;
SLOSMAN, D ;
RIZZOLI, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (03) :555-563
[2]   Leptin reduces ovariectomy-induced bone loss in rats [J].
Burguera, B ;
Hofbauer, LC ;
Thomas, T ;
Gori, F ;
Evans, GL ;
Khosla, S ;
Riggs, BL ;
Turner, RT .
ENDOCRINOLOGY, 2001, 142 (08) :3546-3553
[3]  
CHRISTIANSEN C, 1991, AM J MED, V90, P107
[4]   Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis [J].
Costet, P ;
Legendre, C ;
Moré, J ;
Edgar, A ;
Galtier, P ;
Pineau, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29577-29585
[5]   Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass [J].
Ducy, P ;
Amling, M ;
Takeda, S ;
Priemel, M ;
Schilling, AF ;
Beil, FT ;
Shen, JH ;
Vinson, C ;
Rueger, JM ;
Karsenty, G .
CELL, 2000, 100 (02) :197-207
[6]   Serum leptin level is a regulator of bone mass [J].
Elefteriou, F ;
Takeda, S ;
Ebihara, K ;
Magre, J ;
Patano, N ;
Kim, CA ;
Ogawa, Y ;
Liu, X ;
Ware, SM ;
Craigen, WJ ;
Robert, JJ ;
Vinson, C ;
Nakao, K ;
Capeau, J ;
Karsenty, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) :3258-3263
[7]   BONE MASS IS LOW IN RELATIVES OF OSTEOPOROTIC PATIENTS [J].
EVANS, RA ;
MAREL, GM ;
LANCASTER, EK ;
KOS, S ;
EVANS, M ;
WONG, SYP .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (11) :870-873
[8]   Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms [J].
Gennari, L ;
Becherini, L ;
Falchetti, A ;
Masi, L ;
Massart, F ;
Brandi, ML .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 81 (01) :1-24
[9]   Leptin inhibits osteoclast generation [J].
Holloway, WR ;
Collier, FM ;
Aitken, CJ ;
Myers, DE ;
Hodge, JM ;
Malakellis, M ;
Gough, TJ ;
Collier, GR ;
Nicholson, GC .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (02) :200-209
[10]   Novel phenotypes identified by plasma biochemical screening in the mouse [J].
Hough, TA ;
Nolan, PM ;
Tsipouri, V ;
Toye, AA ;
Gray, IC ;
Goldsworthy, M ;
Moir, L ;
Cox, RD ;
Clements, S ;
Glenister, PH ;
Wood, J ;
Selley, RL ;
Strivens, MA ;
Vizor, L ;
McCormack, SL ;
Peters, J ;
Fisher, EM ;
Spurr, N ;
Rastan, S ;
Martin, JE ;
Brown, SDM ;
Hunter, AJ .
MAMMALIAN GENOME, 2002, 13 (10) :595-602